Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 5, 2006, Pages 1584-1589

  Suzuki, Minoru ^a   Sakurai, Yoshinori ^b   Masunaga, Shinichiro ^a   Kinashi, Yuko ^a   Nagata, Kenji ^a   Maruhashi, Akira ^b   Ono, Koji ^a  

^a Particle Oncology Research Center   (Japan)

^b Kyoto Research Reactor Institute   (Japan)

Author keywords

Boron neutron capture therapy; Malignant pleural mesothelioma

Indexed keywords

COMPUTER SIMULATION; DOSIMETRY; NEUTRONS;

BORON NEUTRON CAPTURE THERAPY (BNCT); LUNGS; MALIGNANT PLEURAL MESOTHELIOMA; SIMULATION ENVIRONMENT FOR RADIOTHERAPY APPLICATIONS (SERA);

RADIOTHERAPY;

AGE; ARTICLE; HUMAN; LUNG; NEUTRON CAPTURE THERAPY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; TUMOR; TUMOR VOLUME;

BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; FEASIBILITY STUDIES; HUMANS; LUNG; MESOTHELIOMA; PLEURAL NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 33751167624     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.08.026     Document Type: Article

References (28)

1. asahi.com. Kubota asbestos leads to 78 deaths. http://www.asahi.com/enclish/Herald-asahi/TKY200507010164.html. Accessed 12/16/2005.
2. Murayama T., Takahashi K., Natori Y., et al. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. J Ind Med 49 (2006) 1-7
3. Peto J., Decarli A., La Vecchia C., et al. The European mesothelioma epidemic. Br J Cancer 79 (1999) 666-672
4. Robinson B.W., Musk A.W., and Lake R. Malignant mesothelioma. Lancet 366 (2005) 397-408
5. Maggi G., Casadio C., Cianci R., et al. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 19 (2001) 346-350
6. Castagneto B., Zai S., Mutti L., et al. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients. Lung Cancer 31 (2001) 303-310
7. Sterman D.H., Recio A., Vachani A., et al. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. Clin Cancer Res 11 (2005) 7444-7453
8. Coderre J.A., and Morris G.M. The radiation biology of boron neutron capture therapy. Radiat Res 151 (1999) 1-18
9. Nigg D.W., Wemple C.A., Wessol D.E., et al. SERA-An advanced treatment planning system for neutron capture therapy and BNCT. Trans Am Nucl Soc 80 (1999) 66-68
10. Wojnecki C., and Green S. A preliminary comparative study of two treatment planning systems developed for boron neutron capture therapy: MacNCTPlan and SERA. Med Phys 29 (2002) 1710-1715
11. Barth R.F., Coderre J.A., Vicente M.G.H., et al. Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res 11 (2005) 3987-4002
12. Kiger J.L., Kiger W.S., Patel H., et al. Effects of boron neutron capture irradiation on the normal lung of rats. Appl Radiat Isot 61 (2004) 969-973
13. Hatabu H., Alsop D.C., Listerud J., et al. T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. Eur J Radiol 29 (1999) 245-252
14. Suzuki M., Sakurai Y., Masunaga S., et al. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors. Int J Radiat Oncol Biol Phys 58 (2004) 892-896
15. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-63
16. Gordon Jr. W., Antman K.H., Greenberger J.S., et al. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 8 (1982) 19-25
17. Ruffie P., Feld R., Minkin S., et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: A retrospective study of 332 patients. J Clin Oncol 7 (1989) 1157-1168
18. Sterman D.H., and Albelda S.M. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Respirology 10 (2005) 266-283
19. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 (2006) 1075-1086
20. Forster K.M., Smythe W.R., Starkschall G., et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: Clinical implementation. Int J Radiat Oncol Biol Phys 55 (2003) 606-616
21. Ahamad A., Stevens C.W., Smythe W.R., et al. Intensity-modulated radiation therapy: A novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55 (2003) 768-775
22. Ahamad A., Stevens C.W., Smythe W.R., et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 9 (2003) 476-484
23. Sakurai Y., and Kobayashi T. Controllability of depth dose distribution for neutron capture therapy at the Heavy Water Neutron Irradiation Facility of Kyoto University Research Reactor. Med Phys 29 (2002) 2338-2350
24. Kato I., Ono K., Sakurai Y., et al. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 61 (2004) 1069-1073
25. Verbakel W.F., Sauerwein W., Hideghety K., et al. Boron concentrations in brain during boron neutron capture therapy: In vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope. Int J Radiat Oncol Biol Phys 55 (2003) 743-756
26. Fukuda H., Honda C., Wadabayashi N., et al. Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: A study of boron neutron capture therapy for malignant melanoma. Melanoma Res 9 (1999) 75-83
27. Wittig A., Moss R.L., Stecher-Rasmussen F., et al. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) petten (EORTC Trials 11961 and 11011). Strahlenther Onkol 181 (2005) 774-782
28. Sauerwein W., Zurlo A., and EORTC Boron Neutron Capture Therapy Group. The EORTC Boron Neutron Capture Therapy (BNCT) Group: Achievements and future projects. Eur J Cancer 38 (2002) 31-34